<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV), a human herpesvirus, establishes a persistent asymptomatic <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> of the circulating B-lymphocyte pool </plain></SENT>
<SENT sid="1" pm="."><plain>The mechanism of virus persistence is not understood but, given the limited lifespan of most B cells in vivo, it seems most likely that EBV-infected cells must gain access to the long-lived memory B-cell pool </plain></SENT>
<SENT sid="2" pm="."><plain>Here we show in an in vitro system that EBV, through expression of the full set of eight virus-coded 'latent' proteins, can protect human B cells from programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> (<z:mpath ids='MPATH_3'>apoptosis</z:mpath>), the deletion mechanism which normally restricts entry into memory </plain></SENT>
<SENT sid="3" pm="."><plain>We have found that EBV-positive Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cell clones retaining the original <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> <z:mp ids='MP_0005384'>cell phenotype</z:mp> and expressing only one of the virus latent proteins, the nuclear antigen EBNA 1, are extremely sensitive to <z:mpath ids='MPATH_3'>apoptosis</z:mpath>; in this respect they resemble the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>'s <z:mpath ids='MPATH_458'>normal</z:mpath> cell of origin found in the germinal centres of lymphoid tissue </plain></SENT>
<SENT sid="4" pm="."><plain>By contrast, isogenic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell clones which have activated expression of <z:hpo ids='HP_0000001'>all</z:hpo> eight EBV latent proteins are resistant to the induction of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>The EBV latent proteins should therefore be seen not just as activators of B-cell proliferation but, perhaps more importantly, as mediators of enhanced B-cell survival </plain></SENT>
</text></document>